Schedule 13D ownership disclosure
SORRENTO THERAPEUTICS IN
Security class unavailable · CUSIP: 83587F202
Event date: 2018-02-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,310,588
- Percent of class
- 1.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-007464
- Form type
- SC 13D
- Filer
- Ally Bridge Group Capital Partners II, L.P.
- CIK
- CIK 1609313
- Filed
- Feb 08, 2018
- Reporting period
- Feb 06, 2018
- Description
- Schedule 13D beneficial ownership